Abstract:Abstract Detection of human immunodeficiency virus (HIV) p24 protein at a single pg/ml concentration in point-of-care (POC) settings is important because it can facilitate acute HIV infection diagnosis with a detection sensitivity approaching that of laboratory-based assays. However, the limit of detection (LOD) of lateral flow immunoassays (LFAs), the most prominent POC diagnostic platform, falls short of that of laboratory protein detection methods such as enzyme-linked immunosorbent assay (ELISA). Here, we report the development and optimization of a thermal contrast amplification (TCA) LFA that will allow ultrasensitive detection of 8 pg/ml p24 protein spiked into human serum at POC, approaching the LOD of a laboratory test. To achieve this aim, we pursued several innovations as follows: (a) defining a new quantitative figure of merit for LFA design based on the specific to nonspecific binding ratio (BR); (b) using different sizes and shapes of gold nanoparticles (GNPs) in the systematic optimization of TCA LFA designs; and (c) exploring new laser wavelengths and power regimes for TCA LFA designs. First, we optimized the blocking buffer for the membrane and running buffer by quantitatively measuring the BR using a TCA reader. The TCA reader interprets the thermal signal (i.e., temperature) of GNPs within the membrane when irradiated by a laser at the plasmon resonance wavelength of the particle. This process results in higher detection and quantitation of GNPs than in traditional visual detection (i.e., color intensity). Further, we investigated the effect of laser power (30, 100, 200 mW), GNP size and shape (30 and 100 nm gold spheres, 150 nm gold-silica shells), and laser wavelength (532, 800 nm). Applying these innovations to a new TCA LFA design, we demonstrated that 100 nm spheres with a 100 mW 532 nm laser provided the best performance (i.e., LOD = 8 pg/ml). This LOD is significantly better than that of the current colorimetric LFA and is in the range of the laboratory-based p24 ELISA. In summary, this TCA LFA for p24 protein shows promise for detecting acute HIV infection in POC settings.

Systematic optimization of UCNPs-LFA for Helicobacter pylori nucleic acid detection at point-of-care

Multiple Cross Displacement Amplification-Based Lateral Flow Biosensor for Rapid and Sensitive Detection of Helicobacter Pylori

A Portable and Universal Upconversion Nanoparticle-Based Lateral Flow Assay Platform for Point-of-care Testing.

Recent advances of upconversion nanoparticles-based lateral flow assays for point-of-care testing

Regulation of probe density on upconversion nanoparticles enabling high-performance lateral flow assays

Regulation of Probe Density on Upconversion Nanoparticles Enabling High-Performance Point-of-Care Testing

A novel loop-mediated isothermal amplification-lateral flow dipstick method for Helicobacter pylori detection

An ultrasensitive J-shaped optical fiber LSPR aptasensor for the detection of Helicobacter pylori

A PDMS-Paper Hybrid Lateral Flow Assay for Highly Sensitive Point-of-Care Nucleic Acid Testing.

Ultrasensitive Rapid Antigen Test by Geometric Lateral Flow Assays and Highly Doped Upconversion Nanoparticles

Oligonucleotide-linked gold nanoparticle aggregates for enhanced sensitivity in lateral flow assays.

A remarkable sensitivity enhancement in a gold nanoparticle-based lateral flow immunoassay for the detection of Escherichia coli O157:H7

Aptamer-superparamagnetic nanoparticles capture coupling siderophore-Fe3+ scavenging actuated with carbon dots to confer an “off-on” mechanism for the ultrasensitive detection of Helicobacter pylori

An integrated colorimetric and photothermal lateral flow immunoassay based on bimetallic Ag-Au urchin-like hollow structures for the sensitive detection of E. coli O157:H7

Smartphone enabled upconversion nanoparticle-based lateral flow strip for ultra-low concentration of methamphetamine detection

A one-pot loop-mediated isothermal amplification platform using fluorescent gold nanoclusters for rapid and naked-eye pathogen detection

The Role of Nanoparticle Design in Determining Analytical Performance of Lateral Flow Immunoassays

An Ultrasensitive PCR-Based CRISPR-Cas13a Method for the Detection of Helicobacter pylori

Development and optimization of thermal contrast amplification lateral flow immunoassays for ultrasensitive HIV p24 protein detection

Lanthanide-Doped Liluf4 Upconversion Nanoprobes for the Detection of Disease Biomarkers

Plasmon-Enhanced Quantum Dot Nanobeads-Based Lateral Flow Assay with Lower Background and Improved Sensitivity